Table 4

Univariate and multivariate analysis of clinical variables affecting 5-year survival of lung cancer patients, including our classifier, with hazard ratios (HR).

Clinical variable

Comparison

p-value (univariate)

p-value (multivariate)

HR


T stage

T1-2 vs. T3-4

1 × 10-7

1.77 × 10-5

2.6


N stage

Nodes uninvolved (N0) vs. Nodes involved (N1-2)

2.84 × 10-12

2.29 × 10-11

2.8


Tumor grade

Low grade (1) vs. intermediate or high grade (2-3)

0.12

0.37

1.3


Our classifier (MAPS)

MAPS- vs. MAPS+ (Expressor)

4.66 × 10-6

0.0001

1.8


Statistically significant results are bolded.

MacDermed et al. BMC Medical Genomics 2010 3:16   doi:10.1186/1755-8794-3-16

Open Data